img

Global Self-administered Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Self-administered Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Self-administered Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Self-administered Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cardiovascular Diseases and Diabetes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Self-administered Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Self-administered Drugs key manufacturers include Abbott Laboratories, Bristol-Myers Squibb, Novartis AG, Eli Lilly and Company, Gilead Sciences and Antares Pharma, etc. Abbott Laboratories, Bristol-Myers Squibb, Novartis AG are top 3 players and held % sales share in total in 2022.
Self-administered Drugs can be divided into Injectable Drugs, Inhaled Drugs and Transdermal Drugs,, etc. Injectable Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Self-administered Drugs is widely used in various fields, such as Cardiovascular Diseases, Diabetes, Osteoporosis and Pain Management, etc. Cardiovascular Diseases provides greatest supports to the Self-administered Drugs industry development. In 2022, global % sales of Self-administered Drugs went into Cardiovascular Diseases filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Self-administered Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories
Bristol-Myers Squibb
Novartis AG
Eli Lilly and Company
Gilead Sciences
Antares Pharma
Segment by Type
Injectable Drugs
Inhaled Drugs
Transdermal Drugs

Segment by Application


Cardiovascular Diseases
Diabetes
Osteoporosis
Pain Management
Hormone Replacement
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Self-administered Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Self-administered Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Self-administered Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Self-administered Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Self-administered Drugs introduction, etc. Self-administered Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Self-administered Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Self-administered Drugs Market Overview
1.1 Self-administered Drugs Product Overview
1.2 Self-administered Drugs Market Segment by Type
1.2.1 Injectable Drugs
1.2.2 Inhaled Drugs
1.2.3 Transdermal Drugs
1.3 Global Self-administered Drugs Market Size by Type
1.3.1 Global Self-administered Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Self-administered Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Self-administered Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Self-administered Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Self-administered Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Self-administered Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Self-administered Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Self-administered Drugs Sales Breakdown by Type (2018-2024)
2 Global Self-administered Drugs Market Competition by Company
2.1 Global Top Players by Self-administered Drugs Sales (2018-2024)
2.2 Global Top Players by Self-administered Drugs Revenue (2018-2024)
2.3 Global Top Players by Self-administered Drugs Price (2018-2024)
2.4 Global Top Manufacturers Self-administered Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Self-administered Drugs Market Competitive Situation and Trends
2.5.1 Self-administered Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Self-administered Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Self-administered Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Self-administered Drugs Market
2.8 Key Manufacturers Self-administered Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Self-administered Drugs Status and Outlook by Region
3.1 Global Self-administered Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Self-administered Drugs Historic Market Size by Region
3.2.1 Global Self-administered Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Self-administered Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Self-administered Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Self-administered Drugs Forecasted Market Size by Region
3.3.1 Global Self-administered Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Self-administered Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Self-administered Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Self-administered Drugs by Application
4.1 Self-administered Drugs Market Segment by Application
4.1.1 Cardiovascular Diseases
4.1.2 Diabetes
4.1.3 Osteoporosis
4.1.4 Pain Management
4.1.5 Hormone Replacement
4.1.6 Others
4.2 Global Self-administered Drugs Market Size by Application
4.2.1 Global Self-administered Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Self-administered Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Self-administered Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Self-administered Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Self-administered Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Self-administered Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Self-administered Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Self-administered Drugs Sales Breakdown by Application (2018-2024)
5 North America Self-administered Drugs by Country
5.1 North America Self-administered Drugs Historic Market Size by Country
5.1.1 North America Self-administered Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Self-administered Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Self-administered Drugs Sales in Value by Country (2018-2024)
5.2 North America Self-administered Drugs Forecasted Market Size by Country
5.2.1 North America Self-administered Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Self-administered Drugs Sales in Value by Country (2024-2034)
6 Europe Self-administered Drugs by Country
6.1 Europe Self-administered Drugs Historic Market Size by Country
6.1.1 Europe Self-administered Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Self-administered Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Self-administered Drugs Sales in Value by Country (2018-2024)
6.2 Europe Self-administered Drugs Forecasted Market Size by Country
6.2.1 Europe Self-administered Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Self-administered Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Self-administered Drugs by Region
7.1 Asia-Pacific Self-administered Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Self-administered Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Self-administered Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Self-administered Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Self-administered Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Self-administered Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Self-administered Drugs Sales in Value by Region (2024-2034)
8 Latin America Self-administered Drugs by Country
8.1 Latin America Self-administered Drugs Historic Market Size by Country
8.1.1 Latin America Self-administered Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Self-administered Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Self-administered Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Self-administered Drugs Forecasted Market Size by Country
8.2.1 Latin America Self-administered Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Self-administered Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Self-administered Drugs by Country
9.1 Middle East and Africa Self-administered Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Self-administered Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Self-administered Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Self-administered Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Self-administered Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Self-administered Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Self-administered Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Self-administered Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Abbott Laboratories Self-administered Drugs Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Bristol-Myers Squibb
10.2.1 Bristol-Myers Squibb Company Information
10.2.2 Bristol-Myers Squibb Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Self-administered Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb Self-administered Drugs Products Offered
10.2.5 Bristol-Myers Squibb Recent Development
10.3 Novartis AG
10.3.1 Novartis AG Company Information
10.3.2 Novartis AG Introduction and Business Overview
10.3.3 Novartis AG Self-administered Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis AG Self-administered Drugs Products Offered
10.3.5 Novartis AG Recent Development
10.4 Eli Lilly and Company
10.4.1 Eli Lilly and Company Company Information
10.4.2 Eli Lilly and Company Introduction and Business Overview
10.4.3 Eli Lilly and Company Self-administered Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Eli Lilly and Company Self-administered Drugs Products Offered
10.4.5 Eli Lilly and Company Recent Development
10.5 Gilead Sciences
10.5.1 Gilead Sciences Company Information
10.5.2 Gilead Sciences Introduction and Business Overview
10.5.3 Gilead Sciences Self-administered Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Gilead Sciences Self-administered Drugs Products Offered
10.5.5 Gilead Sciences Recent Development
10.6 Antares Pharma
10.6.1 Antares Pharma Company Information
10.6.2 Antares Pharma Introduction and Business Overview
10.6.3 Antares Pharma Self-administered Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Antares Pharma Self-administered Drugs Products Offered
10.6.5 Antares Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Self-administered Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Self-administered Drugs Industrial Chain Analysis
11.4 Self-administered Drugs Market Dynamics
11.4.1 Self-administered Drugs Industry Trends
11.4.2 Self-administered Drugs Market Drivers
11.4.3 Self-administered Drugs Market Challenges
11.4.4 Self-administered Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Self-administered Drugs Distributors
12.3 Self-administered Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Injectable Drugs
Table 2. Major Company of Inhaled Drugs
Table 3. Major Company of Transdermal Drugs
Table 4. Global Self-administered Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Self-administered Drugs Sales by Type (2018-2024) & (K MT)
Table 6. Global Self-administered Drugs Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Self-administered Drugs Sales by Type (2018-2024) & (US& Million)
Table 8. Global Self-administered Drugs Market Share in Value by Type (2018-2024)
Table 9. Global Self-administered Drugs Price by Type (2018-2024) & (USD/MT)
Table 10. Global Self-administered Drugs Sales by Type (2024-2034) & (K MT)
Table 11. Global Self-administered Drugs Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Self-administered Drugs Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Self-administered Drugs Sales Market Share in Value by Type (2024-2034)
Table 14. Global Self-administered Drugs Price by Type (2024-2034) & (USD/MT)
Table 15. North America Self-administered Drugs Sales by Type (2018-2024) & (K MT)
Table 16. North America Self-administered Drugs Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Self-administered Drugs Sales (K MT) by Type (2018-2024)
Table 18. Europe Self-administered Drugs Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Self-administered Drugs Sales (K MT) by Type (2018-2024)
Table 20. Asia-Pacific Self-administered Drugs Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Self-administered Drugs Sales (K MT) by Type (2018-2024)
Table 22. Latin America Self-administered Drugs Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Self-administered Drugs Sales (K MT) by Type (2018-2024)
Table 24. Middle East and Africa Self-administered Drugs Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Self-administered Drugs Sales by Company (2018-2024) & (K MT)
Table 26. Global Self-administered Drugs Sales Share by Company (2018-2024)
Table 27. Global Self-administered Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Self-administered Drugs Revenue Share by Company (2018-2024)
Table 29. Global Market Self-administered Drugs Price by Company (2018-2024) & (USD/MT)
Table 30. Global Self-administered Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Self-administered Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Self-administered Drugs as of 2022)
Table 33. Date of Key Manufacturers Enter into Self-administered Drugs Market
Table 34. Key Manufacturers Self-administered Drugs Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Self-administered Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Self-administered Drugs Sales by Region (2018-2024) & (K MT)
Table 38. Global Self-administered Drugs Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Self-administered Drugs Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Self-administered Drugs Sales Market Share in Value by Region (2018-2024)
Table 41. Global Self-administered Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 42. Global Self-administered Drugs Sales by Region (2024-2034) & (K MT)
Table 43. Global Self-administered Drugs Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Self-administered Drugs Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Self-administered Drugs Sales Market Share in Value by Region (2024-2034)
Table 46. Global Self-administered Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 47. Global Self-administered Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Self-administered Drugs Sales by Application (2018-2024) & (K MT)
Table 49. Global Self-administered Drugs Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Self-administered Drugs Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Self-administered Drugs Sales Market Share in Value by Application (2018-2024)
Table 52. Global Self-administered Drugs Price by Application (2018-2024) & (USD/MT)
Table 53. Global Self-administered Drugs Sales by Application (2024-2034) & (K MT)
Table 54. Global Self-administered Drugs Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Self-administered Drugs Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Self-administered Drugs Sales Market Share in Value by Application (2024-2034)
Table 57. Global Self-administered Drugs Price by Application (2024-2034) & (USD/MT)
Table 58. North America Self-administered Drugs Sales by Application (2018-2024) (K MT)
Table 59. North America Self-administered Drugs Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Self-administered Drugs Sales by Application (2018-2024) (K MT)
Table 61. Europe Self-administered Drugs Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Self-administered Drugs Sales by Application (2018-2024) (K MT)
Table 63. Asia-Pacific Self-administered Drugs Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Self-administered Drugs Sales by Application (2018-2024) (K MT)
Table 65. Latin America Self-administered Drugs Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Self-administered Drugs Sales by Application (2018-2024) (K MT)
Table 67. Middle East and Africa Self-administered Drugs Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Self-administered Drugs Sales by Country (2018-2024) & (K MT)
Table 69. North America Self-administered Drugs Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Self-administered Drugs Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Self-administered Drugs Sales Market Share in Value by Country (2018-2024)
Table 72. North America Self-administered Drugs Sales by Country (2024-2034) & (K MT)
Table 73. North America Self-administered Drugs Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Self-administered Drugs Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Self-administered Drugs Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Self-administered Drugs Sales by Country (2018-2024) & (K MT)
Table 77. Europe Self-administered Drugs Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Self-administered Drugs Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Self-administered Drugs Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Self-administered Drugs Sales by Country (2024-2034) & (K MT)
Table 81. Europe Self-administered Drugs Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Self-administered Drugs Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Self-administered Drugs Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Self-administered Drugs Sales by Region (2018-2024) & (K MT)
Table 85. Asia-Pacific Self-administered Drugs Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Self-administered Drugs Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Self-administered Drugs Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Self-administered Drugs Sales by Region (2024-2034) & (K MT)
Table 89. Asia-Pacific Self-administered Drugs Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Self-administered Drugs Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Self-administered Drugs Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Self-administered Drugs Sales by Country (2018-2024) & (K MT)
Table 93. Latin America Self-administered Drugs Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Self-administered Drugs Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Self-administered Drugs Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Self-administered Drugs Sales by Country (2024-2034) & (K MT)
Table 97. Latin America Self-administered Drugs Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Self-administered Drugs Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Self-administered Drugs Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Self-administered Drugs Sales by Country (2018-2024) & (K MT)
Table 101. Middle East and Africa Self-administered Drugs Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Self-administered Drugs Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Self-administered Drugs Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Self-administered Drugs Sales by Country (2024-2034) & (K MT)
Table 105. Middle East and Africa Self-administered Drugs Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Self-administered Drugs Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Self-administered Drugs Sales Market Share in Value by Country (2024-2034)
Table 108. Abbott Laboratories Company Information
Table 109. Abbott Laboratories Introduction and Business Overview
Table 110. Abbott Laboratories Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 111. Abbott Laboratories Self-administered Drugs Product
Table 112. Abbott Laboratories Recent Development
Table 113. Bristol-Myers Squibb Company Information
Table 114. Bristol-Myers Squibb Introduction and Business Overview
Table 115. Bristol-Myers Squibb Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 116. Bristol-Myers Squibb Self-administered Drugs Product
Table 117. Bristol-Myers Squibb Recent Development
Table 118. Novartis AG Company Information
Table 119. Novartis AG Introduction and Business Overview
Table 120. Novartis AG Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 121. Novartis AG Self-administered Drugs Product
Table 122. Novartis AG Recent Development
Table 123. Eli Lilly and Company Company Information
Table 124. Eli Lilly and Company Introduction and Business Overview
Table 125. Eli Lilly and Company Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 126. Eli Lilly and Company Self-administered Drugs Product
Table 127. Eli Lilly and Company Recent Development
Table 128. Gilead Sciences Company Information
Table 129. Gilead Sciences Introduction and Business Overview
Table 130. Gilead Sciences Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 131. Gilead Sciences Self-administered Drugs Product
Table 132. Gilead Sciences Recent Development
Table 133. Antares Pharma Company Information
Table 134. Antares Pharma Introduction and Business Overview
Table 135. Antares Pharma Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 136. Antares Pharma Self-administered Drugs Product
Table 137. Antares Pharma Recent Development
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Self-administered Drugs Market Trends
Table 141. Self-administered Drugs Market Drivers
Table 142. Self-administered Drugs Market Challenges
Table 143. Self-administered Drugs Market Restraints
Table 144. Self-administered Drugs Distributors List
Table 145. Self-administered Drugs Downstream Customers
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Self-administered Drugs Product Picture
Figure 2. Global Self-administered Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Self-administered Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Self-administered Drugs Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Injectable Drugs
Figure 6. Global Injectable Drugs Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Inhaled Drugs
Figure 8. Global Inhaled Drugs Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Transdermal Drugs
Figure 10. Global Transdermal Drugs Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Global Self-administered Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Self-administered Drugs Sales Market Share by Type in 2022 & 2034
Figure 13. North America Self-administered Drugs Sales Market Share in Volume by Type in 2022
Figure 14. North America Self-administered Drugs Sales Market Share in Value by Type in 2022
Figure 15. Europe Self-administered Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Europe Self-administered Drugs Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Self-administered Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Self-administered Drugs Sales Market Share in Value by Type in 2022
Figure 19. Latin America Self-administered Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Self-administered Drugs Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Self-administered Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Self-administered Drugs Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Self-administered Drugs Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Self-administered Drugs Revenue in 2022
Figure 25. Self-administered Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Cardiovascular Diseases
Figure 27. Global Cardiovascular Diseases Sales YoY Growth (2018-2034) & (K MT)
Figure 28. Product Picture of Diabetes
Figure 29. Global Diabetes Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Product Picture of Osteoporosis
Figure 31. Global Osteoporosis Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Product Picture of Pain Management
Figure 33. Global Pain Management Sales YoY Growth (2018-2034) & (K MT)
Figure 34. Product Picture of Hormone Replacement
Figure 35. Global Hormone Replacement Sales YoY Growth (2018-2034) & (K MT)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K MT)
Figure 38. Global Self-administered Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Self-administered Drugs Sales Market Share by Application in 2022 & 2034
Figure 40. North America Self-administered Drugs Sales Market Share in Volume by Application in 2022
Figure 41. North America Self-administered Drugs Sales Market Share in Value by Application in 2022
Figure 42. Europe Self-administered Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Europe Self-administered Drugs Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Self-administered Drugs Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Self-administered Drugs Sales Market Share in Value by Application in 2022
Figure 46. Latin America Self-administered Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Self-administered Drugs Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Self-administered Drugs Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Self-administered Drugs Manufacturing Cost Structure
Figure 51. Self-administered Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries